QMSys_FLT3_NQ v1
Intraday system for the Nasdaq future, made by our Genetic Builder.
A maximum of 4 contracts (Emini or micro) per buyer is allowed to protect liquidity.
The stop size is $2000 for Emini, / $200 for Micro
The recommended capital is 4 * maximum reduction = $4500 per micro
Version 1 has the out-of-sample period of February 28, 2021.
It is recommended to operate both in the v1 and v2 systems, or in the pyramid version v1 and v2 maximum 4 contracts in total.
There is an update from July 4, 2022 that consisted in the removal of one of the output modes and security limit of 3 operations added.
Operations chart
Intraday system
Trades the future of the Nasdaq
Operable symbol
NQ
Out-of-sample period
From 28/02/2021
Price
699 €
Backtest Metrics
Other related products
QMSys_FLT1_NQ
Intraday system for the Nasdaq future, made by our Genetic Builder.
QMSys_FLT3_NQ v2
Intraday system for the Nasdaq future, made by our Genetic Builder. A maximum of 4 contracts (Emini or micro) per buyer is allowed to protect liquidity.
QMSys_FLT4_NQ
Intraday system for the future of SP500 and NQ, made by our Genetic Builder with the improvements of the new 2022 methodology.
Hypothetical performance results have many inherent limitations, some of which are described below.
No representation is being made that any account will or may make profits or losses similar to those shown. In fact, there are often large differences between hypothetical performance results and the actual results subsequently achieved by any particular trading strategy.
One of the limitations of hypothetical performance results is that they are generally prepared with the benefit of hindsight. In addition, counterfactual trading does not involve financial risk, and no counterfactual trading record can fully explain the impact of financial risk on actual trading.
For example, the ability to withstand losses or stick to a particular trading strategy despite trading losses are important points that can also adversely affect actual trading results. There are numerous other factors related to the markets in general or the implementation of any specific trading strategy that cannot be fully considered in the preparation of hypothetical performance results and all of which may adversely affect actual trading results.